These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39111350)
1. Soluble expression of hMYDGF was improved by strain engineering and optimizations of fermentation strategies in Escherichia coli. Su SY; Zheng YS; Mao H; Zhao LB; Zhu MY; Yang YF; Li LT; Wang ZR; He C Protein Expr Purif; 2024 Dec; 224():106565. PubMed ID: 39111350 [TBL] [Abstract][Full Text] [Related]
2. Improved production of D-pantothenic acid in Escherichia coli by integrated strain engineering and fermentation strategies. Zou S; Zhao K; Tang H; Zhang Z; Zhang B; Liu Z; Zheng Y J Biotechnol; 2021 Sep; 339():65-72. PubMed ID: 34352344 [TBL] [Abstract][Full Text] [Related]
3. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it]. Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of T7 RNA polymerase transcription enhances pET-based recombinant protein production in Escherichia coli BL21 (DE3) by suppressing autolysis. Sun XM; Zhang ZX; Wang LR; Wang JG; Liang Y; Yang HF; Tao RS; Jiang Y; Yang JJ; Yang S Biotechnol Bioeng; 2021 Jan; 118(1):153-163. PubMed ID: 32897579 [TBL] [Abstract][Full Text] [Related]
5. [Optimization of fermentation of recombinant human Endostatin (rh-Endostatin) expression in Escherichia coli]. Chang GD; Li ZL; Qin JY; Ma CQ; Luo YZ; Xu P Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):662-6. PubMed ID: 16176112 [TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of 2,4-diacetylphloroglucinol from glucose using engineered Escherichia coli. Liu W; Zhang R; Xian M World J Microbiol Biotechnol; 2020 Jul; 36(9):130. PubMed ID: 32712706 [TBL] [Abstract][Full Text] [Related]
7. Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant. Xiong S; Wang YF; Ren XR; Li B; Zhang MY; Luo Y; Zhang L; Xie QL; Su KY World J Gastroenterol; 2005 Feb; 11(7):1077-82. PubMed ID: 15742420 [TBL] [Abstract][Full Text] [Related]
8. Protein engineering to enhance keratinolytic protease activity and excretion in Escherichia coli and its scale-up fermentation for high extracellular yield. Fang Z; Sha C; Peng Z; Zhang J; Du G Enzyme Microb Technol; 2019 Feb; 121():37-44. PubMed ID: 30554643 [TBL] [Abstract][Full Text] [Related]
9. Metabolic Engineering of De Novo Pathway for the Production of 2'-Fucosyllactose in Escherichia coli. Li C; Li M; Hu M; Zhang T Mol Biotechnol; 2023 Sep; 65(9):1485-1497. PubMed ID: 36652181 [TBL] [Abstract][Full Text] [Related]
10. [Metabolic engineering of Fu W; Li S; Zhao Y; Deng Y Sheng Wu Gong Cheng Xue Bao; 2022 Jul; 38(7):2566-2580. PubMed ID: 35871625 [TBL] [Abstract][Full Text] [Related]
11. High-level production of Arthrobacter aurescens CYC705 nitrilase in Escherichia coli for biosynthesis of iminodiacetic acid. Su E; Lu C; Ma X; Cai W; Zhu S Biotechnol Appl Biochem; 2016 Jul; 63(4):564-71. PubMed ID: 26095946 [TBL] [Abstract][Full Text] [Related]
12. Economic optimization of expression of soluble human epidermal growth factor in Escherichia coli. Liu K; Wang FQ; Zhao M; Gao B; Xu H; Wei D Biotechnol Lett; 2022 Dec; 44(12):1401-1414. PubMed ID: 36269495 [TBL] [Abstract][Full Text] [Related]
13. Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli. Lee WH; Pathanibul P; Quarterman J; Jo JH; Han NS; Miller MJ; Jin YS; Seo JH Microb Cell Fact; 2012 Apr; 11():48. PubMed ID: 22545760 [TBL] [Abstract][Full Text] [Related]
14. [Effects of knockout genes related to outer membrane on extracellular secretion of recombinant proteins in Escherichia coli BL21 (DE3)]. Zhu Y; Zhou Y; Chu J; He B Wei Sheng Wu Xue Bao; 2015 Dec; 55(12):1551-9. PubMed ID: 27101697 [TBL] [Abstract][Full Text] [Related]
15. Use of a derivative of Escherichia coli BL21(DE3) for efficient production of three different recombinant proteins. Zhao JB; Wei DZ Biotechnol Prog; 2007; 23(5):1043-8. PubMed ID: 17715940 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Five Escherichia coli Strains to Achieve the Maximum Yield of a Recombinant Immunotoxin Consisting of an Antibody against VEGF Conjugated with MAP30 Toxin in a Benchtop Bioreactor. Zarei M; Morowvat MH Recent Pat Biotechnol; 2024; 18(1):52-62. PubMed ID: 38205774 [TBL] [Abstract][Full Text] [Related]
17. [Expression and production optimization of sucrose isomerase from Pantoea dispersa in Escherichia coli]. Liu J; Wu J; Chen S Sheng Wu Gong Cheng Xue Bao; 2016 Aug; 32(8):1070-1080. PubMed ID: 29022308 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production. Marisch K; Bayer K; Cserjan-Puschmann M; Luchner M; Striedner G Microb Cell Fact; 2013 Jun; 12():58. PubMed ID: 23758670 [TBL] [Abstract][Full Text] [Related]
19. Expression and purification of soluble B lymphocyte stimulator from recombinant Escherichia coli. Guo QR; Tong WY; Wei DZ; Tao XY Prikl Biokhim Mikrobiol; 2008; 44(2):187-92. PubMed ID: 18669261 [TBL] [Abstract][Full Text] [Related]
20. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli. Yan X; Hu S; Guan YX; Yao SJ Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]